Does insomnia treatment prevent depression?
SLEEP · 13.06.2023 · 46 (6)
DOI: 10.1093/sleep/zsad104 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift SLEEP, online erschienen am 08.04.2023. Verfasst von Elaine M Boland und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Major Depressive Disorder, COVID-19. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIMH NIH HHS, Clinical Science Research and Development.
Themen: Depression, Schlaf
Abstract (Originalsprache)
Rates of major depressive disorder (MDD) are increasing globally, in part due to the coronavirus disease 2019 pandemic, contributing to disease burden. It has long been known that insomnia is intricately connected with depression as indicated by greater depression severity and lower treatment response. Furthermore, insomnia is a significant risk factor for new-onset depression. Treatment of insomnia is thus a logical target for prevention of incidents and recurrent MDD. This systematic review sought to evaluate the current evidence for the preventive effects of insomnia treatment on depression onset. A database search yielded 186 studies, six of which met criteria for inclusion in this review. All of the studies utilized cognitive behavioral treatment for insomnia (CBT-I) as the target intervention and most delivered treatment via a digital platform. Four of the studies found significantly lower rates of MDD onset in those who received CBT-I compared to a control condition. The two remaining studies failed to confirm these effects in primary analyses but secondary analyses suggested evidence of a preventive effect. There was significant methodologic heterogeneity across studies in terms of sample selection, outcomes, and follow-up periods, limiting the ability to draw firm conclusions. The evidence overall is in the direction of insomnia treatment reducing the risk for onset of MDD, but further research is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Cpl. Michael J. Crescenz VA Medical Center, Mental Illness Research Education and Clinical Center, Philadelphia, PA, USA.
ORCID-Profile: Jennifer R Goldschmied, Philip R Gehrman
Förderung
- CSRD VA
- NIMH NIH HHS
- Clinical Science Research and Development
- Department of Veterans Affairs
- National Institute of Mental Health
- National Institutes of Health
Zitieren
APA
Boland, E. M., Goldschmied, J. R., & Gehrman, P. R. (2023). Does insomnia treatment prevent depression?. SLEEP, 46(6). https://doi.org/10.1093/sleep/zsad104
Vancouver
Boland EM, Goldschmied JR, Gehrman PR. Does insomnia treatment prevent depression?. SLEEP. 2023;46(6). doi:10.1093/sleep/zsad104
BibTeX
@article{Boland2023,
author = {Boland, Elaine M and Goldschmied, Jennifer R and Gehrman, Philip R},
title = {Does insomnia treatment prevent depression?},
journal = {SLEEP},
year = {2023},
volume = {46},
number = {6},
doi = {10.1093/sleep/zsad104}
}
EUVIMED